Alpha DNA Investment Management’s Lam Research LRCX Stock Holding History

Alpha DNA Investment Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,057	Closed	-$943K	–	96
2024 Q4	$943K	Buy	+13,057	New	+$990K	0.36%	52
2024 Q3	–	Sell	-10,420	Closed	-$1.11M	–	227
2024 Q2	$1.11M	Buy	10,420 +3,090	+42%	+$296K	0.43%	41
2024 Q1	$712K	Buy	+7,330	New	+$645K	0.26%	85
2023 Q1	–	Sell	-30,730	Closed	-$1.29M	–	180
2022 Q4	$1.29M	Buy	30,730 +10,610	+53%	+$444K	0.46%	56
2022 Q3	$736K	Buy	+20,120	New	+$896K	0.61%	51

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's LRCX Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Lam Research (LRCX) in Q1 2025, closing a stake of 13,057 shares — an estimated $943K sold.

Alpha DNA Investment Management first reported a position in LRCX in Q3 2022 and held it in 5 quarters. The position peaked at $1.29M in Q4 2022. 1,796 funds tracked by Wall St. Rank hold LRCX as of Q1 2025.

Alpha DNA Investment Management reported no remaining Lam Research position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 13,057 Lam Research shares in Q1 2025, an estimated $943K.
Alpha DNA Investment Management first reported a position in Lam Research in Q3 2022 and held it in 5 quarters.
Alpha DNA Investment Management's Lam Research position peaked at $1.29M in Q4 2022.
1,796 funds tracked by Wall St. Rank held Lam Research as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.